Ibex® Design Scaffolds and other Recombinant Proteins

An integrated drug substance/drug product DNA-to-IND offering delivering tailored product-specific solutions for scaffolds and other recombinant proteins, with reliable timelines backed by Lonza’s decades of experience in biologics.

Talk to our experts

15 months* from DNA to IND/IMPD

10 months* from DNA to tox Drug Substance

11 months* from DNA to tox Drug Product

Tailorable technical scope and timelines when necessary to meet your development needs

Take your molecule from DNA to tox drug substance in only 10 months* and IND in 15 months*

Recombinant proteins that do not contain an Fc region, or have an affinity resin available, typically do not fit platform methods developed for mAb-type products. They often have product-specific requirements that impact the development strategy.

Benefit from Lonza’s experienced project teams and subject matter experts with a wealth of knowledge from working on these types of molecules, who can tailor a development strategy to meet your product-specific needs.